1. Home
  2. KLAR vs BIO Comparison

KLAR vs BIO Comparison

Compare KLAR & BIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Klarna Group plc Ordinary Shares

KLAR

Klarna Group plc Ordinary Shares

N/A

Current Price

$13.94

Market Cap

7.7B

Sector

Finance

ML Signal

N/A

Logo Bio-Rad Laboratories Inc.

BIO

Bio-Rad Laboratories Inc.

N/A

Current Price

$382.41

Market Cap

8.0B

Sector

Industrials

ML Signal

N/A

Company Overview

Basic Information
Metric
KLAR
BIO
Founded
2005
1952
Country
United Kingdom
United States
Employees
N/A
N/A
Industry
Finance: Consumer Services
Biotechnology: Laboratory Analytical Instruments
Sector
Finance
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
7.7B
8.0B
IPO Year
2023
1994

Fundamental Metrics

Financial Performance
Metric
KLAR
BIO
Price
$13.94
$382.41
Analyst Decision
Buy
Buy
Analyst Count
16
4
Target Price
$38.00
$339.75
AVG Volume (30 Days)
6.9M
242.4K
Earning Date
05-14-2026
04-30-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
142.61
EPS
N/A
N/A
Revenue
N/A
$2,583,200,000.00
Revenue This Year
$28.56
$2.74
Revenue Next Year
$19.93
$3.20
P/E Ratio
N/A
N/A
Revenue Growth
N/A
0.65
52 Week Low
$12.06
$236.73
52 Week High
$47.48
$396.23

Technical Indicators

Market Signals
Indicator
KLAR
BIO
Relative Strength Index (RSI) 38.29 61.40
Support Level $13.33 $284.88
Resistance Level $15.22 $396.23
Average True Range (ATR) 0.46 9.76
MACD 0.14 -2.77
Stochastic Oscillator 43.71 58.20

Price Performance

Historical Comparison
KLAR
BIO

About KLAR Klarna Group plc Ordinary Shares

Klarna Group PLC is a technology-driven payments company, with operations spanning multiple countries. It connects consumers and merchants with comprehensive payment solutions and tailored advertising solutions, both online and offline. Its payment solutions provide consumers with more control and flexibility over their payments. It is a digital bank and flexible payments provider building the next-generation AI-powered commerce network.

About BIO Bio-Rad Laboratories Inc.

Bio-Rad Laboratories, headquartered in Hercules, California, develops, manufactures, and sells products and solutions for the clinical diagnostics and life sciences markets. In clinical diagnostics (60% of sales), Bio-Rad sells test systems and specialized quality controls for clinical laboratories. In life sciences (40% of sales), it develops and manufactures instruments and reagents used in research, biopharmaceutical production, and food testing and has a leadership position in dPCR technology. The company is geographically diverse, with major markets in the Americas (about 40% of sales), Europe (about 30%), Asia (about 30%), and other. Bio-Rad owns approximately 33% of Sartorius, a lab and bioprocessing supplier that specializes in single-use technology used in biologics manufacturing.

Share on Social Networks: